Telix Pharma Upsizes Convertible Bond Deal to $600 Million
Telix Pharmaceuticals Ltd. raised $600 million from a convertible bond deal that fetched more than expected, in a sign of strong demand for Australia’s largest yet such offering this year....
By Dave Sebastian · Bloomberg
Telix Pharmaceuticals Ltd. raised $600 million from a convertible bond deal that fetched more than expected, in a sign of strong demand for Australia’s largest yet such offering this year. The company’s shares fell.